To report our experience of extracorporeal shock wave lithotripsy (SWL) for patients with uric acid stones. METHODS: From December 1987 to December 2003, a total of 443 patients with uric acid stones in the kidney or ureter accepted SWL using ultrasound-guided lithotripters together with alkali therapy. Among them, 168 patients with an average stone burden of 9.1 mm were treated using an EDAP LT-01 piezoelectric lithotripter. The other patients, with an average stone burden of 9.6 mm, were treated using a Dornier Compact S electromagnetic lithotripter. RESULTS: The average duration of treatment using the EDAP LT-01 device was 52.1 minutes with a pulse frequency of 1.25-2.5 shocks per second at 100% power. The average treatment parameters on the Dornier Compact S device were 3,196 shocks at 14.8 kV. For the EDAP LT-01, the 3-month stone-free rate was 86.4%, with a retreatment rate of 24.2%. For the Dornier Compact S, the 3-month stone-free rate was 90.3%, with a retreatment rate of 29.0%. Auxiliary therapy with the push-back technique was needed in 0.45% of patients with upper ureteral stones that could not be localized using ultrasound. The treatment results were best for stones smaller than 20 mm. No anaesthesia was required for any patient. CONCLUSION: SWL with ultrasound localization for uric acid stones is safe and effective. The combination of SWL with urine alkalization may further improve the stone-free rate. [Asian J Surg 2006;29(1): 
Introduction
Extracorporeal shock wave lithotripsy (SWL) has revolutionized treatment for most patients with urolithiasis since its introduction in the early 1980s. 1, 2 However, uric acid stones were once regarded as a relative contraindication for SWL with the Dornier HM 3 lithotripter because of the difficulty in localizing the radiolucent stones with fluoroscopy. 3, 4 Today, the second generation of lithotripters with ultrasound guidance allow more accurate and harmless localization of radiolucent stones. There have been few reports of treating uric acid stones, which are radiolucent or lightly radioopaque, with SWL. We herein report our series of patients with uric acid stones in the kidney or ureter. These cases Shock Wave Lithotripsy for Uric Acid Stones were treated with SWL using different ultrasound-guided lithotripters in combination with urine alkalization.
Patients and methods
From December 1987 to December 2003, we treated 443 patients with uric acid stones in the kidney or ureter. A total of 168 patients underwent SWL with an EDAP LT-01 lithotripter and 275 patients underwent SWL with a Dornier Compact S lithotripter ( Table 1 ). All patients suffered recurrent pain, gross haematuria and/or urinary obstruction before SWL. The average stone size was calculated from ultrasound as follows: average stone size (mm) = 1/2 (length + width).
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■ SWL FOR URIC ACID STONES ■ Stones smaller than 5 mm, which can be dissolved by alkali therapy before SWL, were excluded from the series.
All patients were evaluated preoperatively using physical and laboratory examinations. Patients with radiolucent stones underwent metabolic evaluation including detailed serum and 24-hour urine biochemical tests. Intravenous urography and ultrasonography were performed before SWL. Retrograde pyelography was used when necessary.
Patients with sterile urine were given oral norfloxacin preoperatively, while those with known bacteriuria were treated with culture-specific antibiotics before SWL. Patients treated with the EDAP LT-01 lithotripter were given 5 mg valium orally 1 hour before SWL and those treated with the Dornier Compact S were given an intramuscular injection of 50 mg petidine at the beginning of lithotripsy after stone localization.
Postoperative ultrasonography was obtained 3 days after SWL for comparison with preoperative ultrasonography; computed tomography was used if necessary. The degree of fragmentation was assessed. Stone-free was defined as a complete absence of any fragments in the upper urinary tract after treatment. All the passed stone fragments were collected and analysed using infrared spectroscopy and polarizing microscopy. These fragments were pure or predominantly uric acid. After SWL, all patients were advised to drink copious amounts of water and take a supplement of sodium bicarbonate (3 g/ day) or potassium citrate (9 g/day) for 2-3 weeks to maintain a urine pH of 6.5-7.0. Patients with preoperative bacteriuria were treated after SWL for 10 days with culture-specific antibiotics and re-examined. If patients were not stone-free 3 days after SWL, follow-up would continue for 3 weeks to 3 months.
Results
In the 168 patients treated with the EDAP LT-01 lithotripter, treatment time for renal stones ranged from 20 to 70 minutes (mean, 48.9 minutes), and for ureteral stones ranged from 48 to 70 minutes (mean, 60.4 minutes). The power was 100% and the pulse frequency was 1.25-2.5 shocks per second. The overall mean SWL treatment time for renal and ureteral stones was 52.1 minutes.
In the 275 patients treated with the Dornier Compact S lithotripter, treatment was started at low voltage, which was then gradually increased. For renal stones, 1,900-3,500 shocks (mean, 2,960) were used at a voltage ranging from 10 to 15 kV (mean, 14.8 kV). For ureteral stones, 3,000-4,000 shocks (mean, 3,294) were used at a voltage ranging from 10 to 16 kV (mean, 14.9). The mean treatment parameters of the Dornier Compact S lithotripter for renal and ureteral stones were 3,196 shocks at 14.8 kV. Table 2 summarizes the results for all stones. For both lithotripters, the overall stone-free rates at 3 weeks and 3 months after SWL were 66.3% and 88.5%, respectively. The stone-free rates and retreatment rates were related to the size and location of the stones; results were better for stones smaller than 20 mm, and retreatment rates for larger stones were higher than those for smaller stones. No anaesthesia was required for in situ SWL with either lithotripter. In two cases, difficulties in detecting upper ureteral stones located at the L4 level with ultrasound-guided lithotripters limited in situ SWL, so a ureteral catheter was inserted under spinal block. The (Table 3) . Only 3% of patients suffered vagal reactions with nausea, vomiting, sweating, bradycardia and hypotension during piezoelectric SWL. If necessary, the procedure was stopped for a moment and patients were given an intramuscular injection of 0.5 mg atropine, then SWL was resumed without problem. After SWL, one patient suffered from urinary tract infection with body temperature higher than 39 C and was treated using intravenous fluids and antibiotics. No significant perinephric haematoma was noted in any case during follow-up. Table 4 shows the results of stone composition analysis by infrared spectroscopy and polarized microscopy.
Discussion
SWL is generally accepted as a standard method for the treatment of renal or ureteral stones. According to our results, the treatment of uric acid stones with ultrasound-guided lithotripters is effective with concurrent application of alkali therapy. Most patients can be stone-free with minimal risk of complications.
Clear localization with ultrasound during SWL is one of the determinants of success. Ultrasound can localize radiolucent uric acid stones of contrast material, ureteral stents and catheters. The ultrasonographic image for stone disintegration during SWL treatment generally includes flattening of the "bright mass" of renal stones and lengthening of the bright mass along the dilated ureter. The fragmentation of lower ureteral stones close to the orifice can be confirmed by a phenomenon called the snowing sign, which occurs when the fragments pass through the orifice into the bladder and fall through the full bladder. However, these images will be obtained only when the stones are located in an expansive chamber where the fragments can disperse. It is not always easy to judge the degree of stone fragmentation. For this reason, if the stones seem to have been fragmented, about 10 minutes of treatment will be routinely added to disintegrate the stones as completely as possible.
Stone location has a notable impact on the results of SWL. SWL with ultrasound-guided lithotripters is easy and efficient for radiolucent uric acid stones smaller than 20 mm, owing to the better direct localization of the stones. Table 2 shows that better results were achieved for renal stones compared with those reported in the literature. 2, 4, 5 Although uric acid stones in the ureter can also be treated with in situ SWL, the ultrasound localization of ureteral stones is often much more difficult than that of renal stones. Thus, it is important that once visualized by ultrasound, upper ureteral stones should be disintegrated adequately in a single SWL session, if possible, in order to avoid the difficulty of localizing the migrated residual stone at a second session. In addition, because of the absence of an expansive chamber around ureteral stones, the fragments forming on the surface of the stones cannot scatter, so a shell will form surrounding the stone. This shell may absorb and reflect shock wave energy, thereby reducing disintegration of the stone core. 6 As a result, more energy and retreatment are often required for ureteral stones than renal stones at a similar burden to achieve a similar stone-free rate. In addition, to improve the disintegration of ureteral stones as well as stones in other locations such as the calyx, we routinely advise patients to take 400-500 mL water 30 minutes before the beginning of SWL. The absorbed water can increase the fluid-stone interface and flush away the fragments to expose the surface of the remaining portion of the stone, thereby facilitating shock 
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■ SWL FOR URIC ACID STONES ■ wave delivery through the fresh fluid-stone interface to destroy the remainder of the stone. According to our limited experience, ultrasound localization of ureteral stones between the L4 level and the lower border of the sacroiliac joint is extremely difficult and even impossible, especially when there is no marked proximal dilatation of the ureter. 7 In this case, stone manipulation is required before SWL. [8] [9] [10] This auxiliary procedure is more suitable for radiolucent ureteral stones that cannot be localized by ultrasound during in situ SWL, and facilitates stone localization as well as the creation of an expansion chamber around the stone to ensure a better result with SWL.
In our series, we also noticed the obvious correlation between the stone-free rate and time after SWL ( Table 2 ). According to our experience, the ultrasound image of stones soon after SWL can sometimes be misleading. Some stones that appeared to be incompletely fragmented or even unchanged on ultrasound images soon after SWL were absent 3 months later, while a few stones that had initially been considered to be completely fragmented were still observed 3 months later. This phenomenon is similar to that of post-SWL fluoroscopy for calculi stones. 11, 12 The reason may partly be related to the resolution of ultrasonography. Therefore, we suggest that a second SWL or auxiliary procedure is not generally necessary within 2-3 months after the first SWL, particularly for stones smaller than 20 mm, if there are no severe complications. Meanwhile, postoperative patients with larger uric acid stones in the kidney that are not verified by ultrasound to have been completely fragmented should not be encouraged to do strong exercises, in case the large residual stones move into the ureter.
The higher stone-free rate with SWL for uric acid stones in our series may be related to the combination with alkali therapy. It is well known that the alkalization of urine is an effective method to prevent the formation of uric acid stones and dissolve uric acid stones that have formed previously. 13, 14 Uric acid stones may be dissolved using intravenous alkali or oral alkali combined with high fluid intake and allopurinol treatment. 15, 16 However, it often takes several months to dissolve pure uric acid stones, and it is very difficult to dissolve mixed stones of uric acid and calcium oxalate. Theoretically, alkalization of urine may improve the stone-free rate of SWL for uric acid stones in three ways: the surface area of the stone may be greatly increased after disintegration of the primary stone, thereby facilitating the dissolution of the residual stone; the insoluble outer oxalate layers of some uric acid stones are broken off by shock waves, so alkali therapy can dissolve the uric acid cores of the stones; and the residual fragments falling into the ureter after SWL, which may not be localized by ultrasound, may be dissolved by alkaline urine. Furthermore, this mechanism shows that the complete clearance of stone particles as a "stone embryo" is also essential for preventing stone recurrence.
Our data show that SWL with the second generation of ultrasound-guided lithotripters for uric acid stones in the kidney or ureter is safe and effective. SWL combined with alkali therapy may further improve the efficacy of treatment of uric acid stones.
